CXCL16: A Potential Drug Target Or Biomarker (G58191)

Target Name: CXCL16

NCBI ID: G58191

CXCL16

CXCL16: A Potential Drug Target Or Biomarker

CXCL16: A C-X-C Motif Chemokine Ligand 16 (CXCL16) is a protein that has been identified as a potential drug target or biomarker. It is a member of the C-X-C motif family, which is a common structural motif found in proteins that play important roles in various cellular processes. CXCL16 is expressed in a variety of tissues and has been shown to play a role in several physiological processes, including immune responses, inflammation, and cell signaling.

The CXCL16 protein is composed of 184 amino acid residues and has a molecular weight of 21.1 kDa. It is expressed in various tissues, including the brain, spleen, heart, and lymphoid organs. CXCL16 is a glycoprotein and has a high glycophosphorylation status, which suggests that it is involved in cellular signaling processes.

One of the most significant features of CXCL16 is its C-X-C motif, which is a conserved structural motif that is found in many proteins that belong to the C-X-C motif family. The C-X-C motif is a characteristic motif that is composed of a specific sequence of amino acids that is involved in protein-protein interactions and may be involved in the regulation of various cellular processes.

CXCL16 has been shown to play a role in several physiological processes, including immune responses, inflammation, and cell signaling. For example, CXCL16 has been shown to regulate the immune response by promoting the production of natural killer cells and affecting the production of antibodies. CXCL16 has also been shown to play a role in the regulation of inflammation by promoting the production of pro-inflammatory cytokines and affecting the production of anti-inflammatory cytokines.

In addition to its role in immune and inflammatory processes, CXCL16 has also been shown to play a role in cell signaling. For example, CXCL16 has been shown to promote the production of neurotransmitters, such as dopamine and serotonin, and to regulate the release of these neurotransmitters. CXCL16 has also been shown to play a role in the regulation of cellular signaling by affecting the intracellular signaling pathways of several neurotransmitters, including dopamine, serotonin, and GABA.

Given its involvement in several physiological processes, CXCL16 is a potential drug target or biomarker for a variety of diseases. For example, CXCL16 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and has been shown to be involved in the regulation of pain perception. In addition, CXCL16 has also been shown to be involved in the regulation of inflammation and has been shown to play a role in the development of inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease.

In conclusion, CXCL16 is a protein that has been identified as a potential drug target or biomarker. Its C-X-C motif and its involvement in several physiological processes make it a promising candidate for further research. Further studies are needed to fully understand the role of CXCL16 in cellular signaling and its potential as a drug target or biomarker.

Protein Name: C-X-C Motif Chemokine Ligand 16

Functions: Acts as a scavenger receptor on macrophages, which specifically binds to OxLDL (oxidized low density lipoprotein), suggesting that it may be involved in pathophysiology such as atherogenesis (By similarity). Induces a strong chemotactic response. Induces calcium mobilization. Binds to CXCR6/Bonzo

The "CXCL16 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CXCL16 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets